An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

NCT00621140 ·Status: COMPLETED ·Phase: PHASE3

Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

NCT00551564 ·Status: COMPLETED ·Phase: PHASE1

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

NCT00329225 ·Status: COMPLETED ·Phase: PHASE4

A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus

NCT00212641 ·Status: COMPLETED ·Phase: PHASE2

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

NCT01469065 ·Status: COMPLETED ·Phase: PHASE1

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

NCT02121717 ·Status: COMPLETED ·Phase: PHASE3

A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin

NCT01729403 ·Status: COMPLETED ·Phase: PHASE2

Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects

NCT00908271 ·Status: COMPLETED ·Phase: PHASE1

Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes

NCT00549874 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy

NCT00515632 ·Status: COMPLETED ·Phase: PHASE3

Rosiglitazone on Microalbuminuria in Type 2 Diabetics

NCT00500955 ·Status: COMPLETED ·Phase: PHASE3

A Study In Patients With Type 2 Diabetes Mellitus

NCT00256867 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

NCT02211261 ·Status: COMPLETED ·Phase: PHASE1

Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

NCT05158244 ·Status: COMPLETED ·Phase: PHASE1

A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT06191328 ·Status: NOT_YET_RECRUITING ·Phase: NA

Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK

NCT00995995 ·Status: COMPLETED

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

NCT00495469 ·Status: COMPLETED ·Phase: PHASE2

A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

NCT00067951 ·Status: COMPLETED ·Phase: PHASE3

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

NCT06567041 ·Status: COMPLETED ·Phase: PHASE1

A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy

NCT01871428 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Albiglutide in Type 2 Diabetes

NCT00849017 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

NCT07073170 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

NCT00817778 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

NCT01665352 ·Status: COMPLETED ·Phase: PHASE2

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

NCT01691755 ·Status: COMPLETED ·Phase: PHASE3